Daiken Biomedical Co., Ltd. (TPE:7780)

Taiwan · Delayed Price · Currency is TWD

15.20

-0.25 (-1.62%)

At close: Oct 30, 2026

Market Cap	12.20B +21.4%
Revenue (ttm)	2.19B +34.3%
Net Income	424.96M +72.1%
EPS	0.55 +34.5%
Shares Out	805.56M
PE Ratio	27.61
Forward PE	n/a
Dividend	0.70 (4.60%)
Ex-Dividend Date	Sep 3, 2026

Volume	1,170,043
Open	15.45
Previous Close	15.45
Day's Range	15.10 - 15.45
52-Week Range	15.20 - 29.40
Beta	0.39
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 12, 2026

About Daiken Biomedical

Daiken Biomedical Co., Ltd. engages in the research and development of healthy food products. The company was founded in 2018 and is based in Taipei, Taiwan. Daiken Biomedical Co., Ltd. operates as a subsidiary of Sunfun Info Co., Ltd. [Read more]

Industry Packaged Foods

Sector Consumer Staples

Founded 2018

Country Taiwan

Stock Exchange Taiwan Stock Exchange

Ticker Symbol 7780

Full Company Profile

Financial Performance

In 2025, Daiken Biomedical's revenue was 1.90 billion, an increase of 39.10% compared to the previous year's 1.36 billion. Earnings were 337.87 million, an increase of 217.01%.

Financial Statements